Yale Jen
Stock Analyst at Laidlaw & Co.
(0.06)
# 4,414
Out of 5,178 analysts
15
Total ratings
6.67%
Success rate
-20.45%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTN Palatin Technologies | Initiates: Buy | $60 | $20.65 | +190.56% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.50 | +1,204.96% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $2.40 | +816.67% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $0.88 | +467.28% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $31.86 | +229.57% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $7.81 | +143.28% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $120 | $6.30 | +1,804.76% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $109.48 | -56.16% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $4.71 | +9,984.93% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $1.47 | +15,206.12% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.28 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.38 | +2,561.34% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.01 | - | 1 | Aug 15, 2023 |
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $20.65
Upside: +190.56%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.50
Upside: +1,204.96%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $2.40
Upside: +816.67%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $0.88
Upside: +467.28%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $31.86
Upside: +229.57%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $7.81
Upside: +143.28%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $120
Current: $6.30
Upside: +1,804.76%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $109.48
Upside: -56.16%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $4.71
Upside: +9,984.93%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $1.47
Upside: +15,206.12%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.28
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.38
Upside: +2,561.34%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.01
Upside: -